Lipocine Inc. — Director's Dealing 2019

Jun 14, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lipocine Inc. (LPCN)
CIK: 0001535955
Period of Report: 2019-06-12

Reporting Person: HILL STEPHEN A (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-12	Stock Option (Right to Buy)	$1.68	A	10000	Acquired	2029-06-12	Common Stock (10000)	Direct

Footnotes

F1: 100% vesting one year from date of grant